美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Eaton Vance Massachusetts Muni

12.28

0.0000

成交量：- -

成交額：- -

市值：2,171.74萬

市盈率：-31.18

高：12.28

開：12.28

低：12.28

收：12.28

52周最高：13.97

52周最低：11.77

股本：176.85萬

流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.3939

每股收益(LYR):-0.3939

淨資產收益率：--

總資產收益率：--

市淨率：0.86

市盈率(LYR):-31.18

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

I-MAB（Nasdaq: IMAB）正式更名為新橋生物（NovaBridge Biosciences；Nasdaq: NBP），股票交易將於2025年10月30日正式生效，新品牌標誌着其向全球生物科技平台型公司的戰略轉型

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MAB"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAB\",,,,,undefined,":{"symbol":"MAB","market":"US","secType":"STK","nameCN":"Eaton Vance Massachusetts Muni","latestPrice":12.28,"timestamp":1575925200000,"preClose":12.28,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":1768514,"eps":-0.3939,"marketStatus":"退市","change":0,"latestTime":"12-09 16:00:00 EST","open":12.28,"high":12.28,"low":12.28,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.3939,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":12.28,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAB\",,,,,undefined,":{"symbol":"MAB","floatShares":0,"roa":"--","roe":"--","lyrEps":-0.3939,"shares":1768514,"dividePrice":0,"high":12.28,"amplitude":0,"preClose":12.28,"low":12.28,"week52Low":11.77,"pbRate":"0.86","week52High":13.97,"institutionHeld":0.0082,"latestPrice":12.28,"eps":-0.3939,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.3939,"open":12.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-12-12","symbol":"MAB","amount":0.0533,"name":"Eaton Vance Massachusetts Muni","currency":"USD","type":"dividend","dateTimestamp":1544590800000},{"market":"US","date":"2018-11-21","symbol":"MAB","amount":0.0434,"name":"Eaton Vance Massachusetts Muni","currency":"USD","type":"dividend","dateTimestamp":1542776400000},{"market":"US","date":"2018-10-23","symbol":"MAB","amount":0.0434,"name":"Eaton Vance Massachusetts Muni","currency":"USD","type":"dividend","dateTimestamp":1540267200000},{"market":"US","date":"2018-09-20","symbol":"MAB","amount":0.0434,"name":"Eaton Vance Massachusetts Muni","currency":"USD","type":"dividend","dateTimestamp":1537416000000},{"market":"US","date":"2018-08-23","symbol":"MAB","amount":0.0434,"name":"Eaton Vance Massachusetts Muni","currency":"USD","type":"dividend","dateTimestamp":1534996800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAB\",market:\"US\",,,undefined,":[{"executeDate":"2017-01-20","recordDate":null,"paymentDate":null,"value":0.0492,"currency":"USD"},{"executeDate":"2017-02-16","recordDate":null,"paymentDate":null,"value":0.0492,"currency":"USD"},{"executeDate":"2017-03-22","recordDate":null,"paymentDate":null,"value":0.0467,"currency":"USD"},{"executeDate":"2017-04-19","recordDate":null,"paymentDate":null,"value":0.0467,"currency":"USD"},{"executeDate":"2017-05-22","recordDate":null,"paymentDate":null,"value":0.0434,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAB\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2579907397","title":"I-MAB（Nasdaq: IMAB）正式更名為新橋生物（NovaBridge Biosciences；Nasdaq: NBP），股票交易將於2025年10月30日正式生效，新品牌標誌着其向全球生物科技平台型公司的戰略轉型","url":"https://stock-news.laohu8.com/highlight/detail?id=2579907397","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579907397?lang=zh_tw&edition=fundamental","pubTime":"2025-10-29 21:56","pubTimestamp":1761746160,"startTime":"0","endTime":"0","summary":"此项更名决议已获得公司于2025年10月24日召开的特别股东大会高票通过，并获董事会批准。在部分第三方网站或应用程序上，若搜索\"NovaBridge Biosciences\"或\"NBP\"时，可能暂时无法查询到公司美国存托股份在2025年10月30日之前的历史交易数据。我们正积极推进givastomig全球随机对照 II 期研究，预计于2026年第一季度完成首例患者入组。VIS-101预计将于2026年具备开展III期试验的条件。此次收购已通过新成立的子公司Visara完成。新桥生物成为Visara的控股股东，并拥有VIS-101的全球权益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4810152_ZH10152_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4139",".IXIC","NBP","BK4505","MNQmain","USAW.SI","NVIW.SI","QID","TQQQ","BK4535","QLD","IMAB","MAB","USJW.SI","BK4526","NQmain","SQQQ","PSQ","TSYW.SI"],"gpt_icon":1}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MAB\",params:#limit:6,delay:false,,,undefined,":[]}}